Showing results (641-650 of 692) with videos related to
Sort By:
Pageof 70
Medrxiv : the Preprint Server for Health Sciences|May 10, 2023
AI-based histologic scoring enables automated and reproducible assessment of enrollment criteria and endpoints in NASH clinical trialsJanani S Iyer, Harsha Pokkalla, Charles Biddle-Snead, et al.Hepatology (Baltimore, Md.)|December 10, 2017
Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitisZobair M Younossi, Rohit Loomba, Mary E Rinella, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 18, 2023
aMAP Score and Its Combination With Liver Stiffness Measurement Accurately Assess Liver Fibrosis in Chronic Hepatitis B PatientsRong Fan, Guanlin Li, Ning Yu, et al.Hepatology (Baltimore, Md.)|April 5, 2020
Circulating Extracellular Vesicles Carrying Sphingolipid Cargo for the Diagnosis and Dynamic Risk Profiling of Alcoholic HepatitisTejasav S Sehrawat, Juan P Arab, Mengfei Liu, et al.Plos One|April 15, 2022
Validation of the accuracy of the FAST™ score for detecting patients with at-risk nonalcoholic steatohepatitis (NASH) in a North American cohort and comparison to other non-invasive algorithmsTinsay A Woreta, Mark L Van Natta, Mariana Lazo, et al.Nature Medicine|February 16, 2023
Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a/b trialArun J Sanyal, Patricia Lopez, Eric J Lawitz, et al.Hepatology (Baltimore, Md.)|July 27, 2026
Implications of new obesity definitions in the classification and outcomes of patients with MASLDJie Cai, Terry Cheuk-Fung Yip, Huapeng Lin, et al.Nature Reviews. Gastroenterology & Hepatology|September 27, 2025
Clinical trial design, biomarkers and end points in metabolic and alcohol-related liver diseaseLuis Antonio Diaz, Maja Thiele, Alexandre Louvet, et al.Hepatology Communications|July 21, 2018
Metabolomic-based noninvasive serum test to diagnose nonalcoholic steatohepatitis: Results from discovery and validation cohortsRebeca Mayo, Javier Crespo, Ibon Martínez-Arranz, et al.The New England Journal of Medicine|February 7, 2024
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver FibrosisStephen A Harrison, Pierre Bedossa, Cynthia D Guy, et al.Pageof 70